Cellyan Biotechnology (HKPD) vs McKesson (MCK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
McKesson is the larger company by market cap ($109.18 billion vs $4.8 million), about 22823.1 times the size. McKesson pays a dividend yielding 0.35%, while Cellyan Biotechnology does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HKPD | MCK |
|---|---|---|
| Share price | $0.097 | $936.45 |
| Market cap | $4.78M | $109.18B |
| 1-day change | -3.77% | +0.67% |
| YTD return | — | +13.41% |
| 1-year return | — | +23.09% |
| 5-year return | — | +355.63% |
| P/E ratio (TTM) | — | 25.10 |
| Forward P/E | — | 18.56 |
| EPS (TTM) | $-0.07 | $37.31 |
| Dividend yield | 0.00% | 0.35% |
| Annual dividend | $0.00 | $3.28 |
| Revenue (latest FY) | — | $403.43B |
| Revenue growth (YoY) | — | +12.36% |
| Net income (latest FY) | — | $4.76B |
| Gross margin | — | 3.61% |
| Operating margin | — | 1.54% |
| Net margin | — | 1.18% |
| 52-week high | $1.72 | $999.00 |
| 52-week low | $0.095 | $723.68 |
| Distance from 52-week high | -94.36% | -6.26% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +4.37% |
| Average volume | 3.78M | 918.02K |
| Shares outstanding | 42.17M | 116.59M |
| Employees | 11 | 41,600 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- McKesson is about 22823.1 times larger than Cellyan Biotechnology by market value ($109.18B vs $4.78M).
About Cellyan Biotechnology
HKPD stock →Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services.
Health Care · Other Pharmaceuticals · 11 employees
About McKesson
MCK stock →McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Health Care · Other Pharmaceuticals · 41,600 employees
HKPD vs MCK FAQ
Which is bigger, Cellyan Biotechnology or McKesson?
McKesson (MCK) is larger, with a market capitalization of $109.18B compared with $4.78M for Cellyan Biotechnology (HKPD).
Which pays a higher dividend, Cellyan Biotechnology or McKesson?
McKesson pays a dividend yielding 0.35%, while Cellyan Biotechnology does not currently pay a regular dividend.
Are Cellyan Biotechnology and McKesson in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.